Overexpression of both the MUC1 and FRA receptors on the breast cancer highlight the potential application of the radiolabeled MUC1-conjugated folate hybrid peptide as dual-receptor-targeting imaging probes for breast carcinoma imaging. The gene discussed is MUC1; the disease is breast cancer.